by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Based on the available evidence, we conclude that ayahuasca shows promise as a therapeutic tool by enhancing self-acceptance and allowing safe exposure to emotional events. We postulate that ayahuasca could be of use in the treatment of impulse-related, personality...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
In summary, this review has provided evidence that the beneficial synergistic effects of MDMA with psychotherapy are attributed, at least in part, to the complex neuropharmacological profile of this entactogen creating a neural setting primed to facilitate new...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
PY dose dependently increased scores of all 5D-ASC core dimensions. Only one subject reacted with transient anxiety to HD PY. Compared with PL, MD and HD PY led to a 50% reduction of performance in the FAIR test. “General inactivation”, “emotional...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
One subject experienced transient hypertension without relation to anxiety or somatic symptoms, but no other significant adverse effects were observed. Marked decreases in OCD symptoms of variable degrees were observed in all subjects during 1 or more of the testing...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
This study replicated the previous model, finding a state of surrender before ingestion a key predictor of optimal experience and preoccupation a key predictor of adverse experience. Additional predictors added to the explanatory power for optimal and adverse...
